Pancreatic Cancer Research

Digest Map Explore About

Open data from ClinicalTrials.gov, Europe PMC, NIH RePORTER and OpenAlexFor research and education, not medical adviceAbout this project

The Pancreatic Cancer Research Digest

New trials, papers and changes to existing records, compiled daily from the public registries

Tuesday, August 25, 202610 items · 0 changes to existing records

← Previous day Next day →

New paper

Erratum: Disulfiram combined with chemoimmunotherapy potentiates pancreatic cancer treatment efficacy through the activation of cGAS-STING signaling pathway via suppressing PARP1 expression.

Why it was picked newest record on or before this date

DOI 10.62347/fsin8036 ↗ Aug 25, 2026

In this edition

New trials: 0
New papers: 10
New grants: 0
Other new records: 0
Status changes: 0
Results posted: 0
Retractions: 0
Other updates: 0

New paper

Unexpected Long-Term Survival in Resected Pancreatic Ductal Adenocarcinoma Harboring KRAS G12R with an Ultra-Low-VAF SMAD4 Mutation: A Case Report and Mini-Review.

Why it was picked newest record on or before this date

DOI 10.3390/reports9030285 ↗ Aug 25, 2026

New paper

Adjuvant Therapy in Pancreatic Ductal Adenocarcinoma-Past, Present, and Future.

Why it was picked newest record on or before this date

DOI 10.3390/cancers18172754 ↗ Aug 25, 2026

New paper

Exploratory Multi-Platform Bioinformatic Analysis of MEAK7 and Its Molecular, Survival, and Immune Associations in Pancreatic Ductal Adenocarcinoma.

Why it was picked newest record on or before this date

DOI 10.3390/ijms27177610 ↗ Aug 25, 2026

New paper

Multi-modal digital twin model outperforms conventional biomarker stratification in pancreatic cancer.

Why it was picked newest record on or before this date

DOI 10.3389/frai.2026.1873681 ↗ Aug 25, 2026

Also today

New paper

Perioperative management of pancreaticoduodenectomy for pancreatic ductal adenocarcinoma in a patient with moyamoya disease: a rare case report.

DOI 10.3389/fonc.2026.1912208 ↗ Aug 25, 2026

New paper

RAS signaling and remodeling of the immune microenvironment in pancreatic ductal adenocarcinoma: implications of emerging RAS-targeted therapy.

DOI 10.3389/fcell.2026.1948028 ↗ Aug 25, 2026

New paper

Ecological Modelling of Dietary Microplastic Exposure and Geographic-Patterns of Pancreatic Cancer Mortality in Italy

DOI 10.20944/preprints202608.1713.v1 ↗ Aug 25, 2026

New paper

Burden of early-onset pancreatic cancer and its association with risk factors in women of childbearing age.

What changed

Change tracking began 4 November 2026, after this day, so only its new records are listed.

Compiled by the knowledge layer from its change log. Every headline opens the underlying record; every identifier links to its source.

DOI 10.1371/journal.pone.0356644

·

Aug 25, 2026

New paper

Surface-engineered milk-derived extracellular vesicles enable oral miRNA therapy against immunosuppressive pancreatic cancer.

DOI 10.1016/j.mtbio.2026.103600 ↗ Aug 25, 2026